Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P52948
UPID:
NUP98_HUMAN
Alternative names:
-
Alternative UPACC:
P52948; Q8IUT2; Q8WYB0; Q96E54; Q9H3Q4; Q9NT02; Q9UF57; Q9UHX0; Q9Y6J4; Q9Y6J5
Background:
Nuclear pore complex protein Nup98-Nup96 plays a crucial role in nuclear pore complex assembly and maintenance, facilitating bidirectional transport across the nuclear envelope. It anchors key nucleoporins and, alongside DHX9, activates transcription and splicing of specific genes. Additionally, it interacts with HIV-1 proteins, potentially aiding viral integration into the host nucleus.
Therapeutic significance:
Understanding the role of Nuclear pore complex protein Nup98-Nup96 could open doors to potential therapeutic strategies.